Delivery Order SPE2DB20D2014-SPE2DB23FD13F
Award Date 8/21/23
Potential Completion Date 8/22/23
Potential Value $3.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,504.16 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561468430, which is Lantus 100 unit/ml vials packaged in quantities of 10 ml. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 11, 2023 through July 12, 2023. As the DLA supports the procurement of medical supplies and equipment for the Department of Defense, this delivery...
- The Defense Logistics Agency awarded a $395.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of Lantus 100 unit/ml vials. The order is for 10 ml vials of the insulin medication and will be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania. The period of performance is August 16-17, 2023. No subcontractors or set aside designations were identified. This order is likely in support of the DLA's medical supply chain and will...
- The Defense Logistics Agency awarded a $158,320 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561327940 Lantus 100 unit/ml vials, 10 ml per vial. To be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, the order is in support of the Defense Logistics Agency's medical supply procurement programs. No subcontractors or set aside designations were identified. The delivery order has a period of performance from June 23, 2023 through...
- The Defense Logistics Agency awarded a $4,517.97 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561707404 Lantus 100 unit/ml vials in 10ml quantities. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with all supplies to be delivered between...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred eighteen thousand seven hundred forty dollars to Amerisourcebergen Drug Corporation for the supply of Lantus 100 unit/ml vials. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of ten boxes containing one hundred vials each of the insulin product to a facility in Conshohocken, Pennsylvania. Performance is required between July 28...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $471.22 to supply Lantus 100 unit/ml vials. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the insulin medication to a location in Conshohocken, Pennsylvania by September 14, 2023 under the terms of the order. The Defense Logistics Agency functions to support military readiness by procuring and providing logistics support for supplies such as medical...
- The Defense Logistics Agency awarded a $444.91 delivery order to Amerisourcebergen Drug Corporation for the supply of Lantus 100 unit/ml vials. The firm fixed price order is for 10ml vials of the insulin medication and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by August 8, 2023 to support DLA requirements. No set aside designation or subcontractors were identified. DLA manages the global supply chain for the Department of Defense, procuring critical...
- The Defense Logistics Agency awarded a $1,043 delivery order to Amerisourcebergen Drug Corporation for Lantus 100 unit/ml vials. Under this firm fixed price contract, Amerisourcebergen will provide 10 ml vials of the insulin medication to a location in Conshohocken, Pennsylvania by September 6, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, procuring diverse medical supplies and equipment to support military readiness. No set...
- The Defense Logistics Agency Troop Support Medical awarded a $720.80 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 4561829215, which is Lantus 100 unit/ml vials packaged in quantities of 10 ml. The place of performance will be Amerisourcebergen's location in Conshohocken, Pennsylvania. The period of performance is limited to August 16-17, 2023. No major subcontractors or set aside designations were indicated. This delivery order...
- The Defense Logistics Agency awarded a $798 delivery order to Amerisourcebergen Drug Corporation for Lantus 100 unit/ml vials. The firm fixed price order is for 10ml vials of the insulin medication and will be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 15, 2023 in support of DLA programs. No subcontractors or set aside designations were identified. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract, which provides medical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FD13FDelivery Order
The Defense Logistics Agency awarded a $3,218.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561887993 Lantus 100 unit/ml vials in quantities of 10ml each. Performance will take place at the prime contractor's facility located in Conshohocken, Pennsylvania. The order is funded by the Defense Logistics Agency and has a period of performance spanning August 21, 2023 through August 22, 2023. No subcontractors or set aside designations were identified. The delivery order appears to be a small purchase of insulin supplies for DLA to support its medical logistics programs.
Generated 12/20/23, 5:29 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/21/23 |